- Abstract viewed - 1219 times
- PDF downloaded - 495 times
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright
© Medicine and Pharmacy Reports, 2023
Affiliations
Nicu Cătălin Drăghici
Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania IMOGEN Institute, Centre of Advanced Research Studies, Cluj-Napoca, Romania; RoNeuro Institute, Centre for Neurological Research and Diagnostic, Cluj-Napoca, Romania
Elena Olariu
Nuclear Medicine Department, "Prof.Dr. Ion Chiricuta" Institute of Oncology, Cluj-Napoca, Romania
Tudor Dimitrie Lupescu
Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania RoNeuro Institute, Centre for Neurological Research and Diagnostic, Cluj-Napoca, Romania Neurology Department, “Prof Dr. Agrippa Ionescu” Emergency Clinical Hospital, Bucharest, Romania;
Fior Dafin Mureșanu
Department of Clinical Neurosciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania RoNeuro Institute, Centre for Neurological Research and Diagnostic, Cluj-Napoca, Romania
How to Cite
Acute onset of Lambert Eaton myasthenic syndrome in prostate adenocarcinoma: a case report
Abstract
Lambert Eaton myasthenic syndrome (LEMS) is a rare disorder of the neuromuscular junction. The representative clinical triad consists of proximal muscular weakness, areflexia and autonomic dysfunction. The diagnosis is based on the clinical findings confirmed by voltage-gated calcium channels antibody titer and neurophysiology. We present a 69 year old male with prostate adenocarcinoma and 30 years history of smoking, referred for muscle weakness in the lower limbs and difficulty to climb the stairs.